When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease

When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease

Advanced therapy medicinal products (ATMPs) offer new prospects to improve the treatment of conditions with unmet medical needs. Kidney diseases are a current major health concern with an increasing global prevalence. Chronic renal failure appears after many years of impairment, which opens a tempor...

Full description

Bibliographic Details
Main Authors:	Sandra Calcat-i-Cervera, Clara Sanz-Nogués, Timothy O'Brien
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Medicine
Subjects:	mesenchymal stromal cells (MSCs) tissue source good manufacturing practice (GMP) advanced therapy medicinal products (ATMPs) kidney disease cell therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.728496/full

Similar Items

MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
by: Chantal Lechanteur, et al.
Published: (2021-05-01)

Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents
by: Clara Sanz-Nogués, et al.
Published: (2021-06-01)

Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01)

Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
by: Seda Ballikaya, et al.
Published: (2020-11-01)

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
by: Sara Rolandsson Enes, et al.
Published: (2021-04-01)

Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01)

Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles
by: Darja Marolt Presen, et al.
Published: (2019-11-01)

Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
by: Premkumar Jayaraman, et al.
Published: (2021-04-01)

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection
by: Maria A. Avanzini, et al.
Published: (2021-04-01)

Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
by: Dragan Primorac, et al.
Published: (2021-09-01)

Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses
by: Miguel Espina, et al.
Published: (2016-03-01)

Mesenchymal stromal cell therapy in ischemic stroke
by: Zhang Y, et al.
Published: (2016-11-01)

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
by: Juliette Peltzer, et al.
Published: (2018-09-01)

Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies
by: Raphael Gorodetsky, et al.
Published: (2021-05-01)

Trophic Actions of Bone Marrow-Derived Mesenchymal Stromal Cells for Muscle Repair/Regeneration
by: Lucia Formigli, et al.
Published: (2012-10-01)

Mesenchymal stem cell based treatment for microvascular and secondary complications of Diabetes Mellitus
by: Grace C Davey, et al.
Published: (2014-06-01)

Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
by: Aidan M. Kirkham, et al.
Published: (2021-09-01)

Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit
by: Mohammad Reza Mokhber Dezfouli, et al.
Published: (2018-12-01)

Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
by: Katia Mareschi, et al.
Published: (2020-05-01)

Editorial: Current Progress in Mesenchymal Stem/Stromal Cell Research
by: Lindolfo da Silva Meirelles, et al.
Published: (2021-02-01)

Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells
by: Lidan Luo, et al.
Published: (2020-10-01)

Mesenchymal stromal cells for osteonecrosis
by: S. Elgaz, et al.
Published: (2020-10-01)

Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy
by: Zeli Yin, et al.
Published: (2018-12-01)

Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
by: Xuegang Yuan, et al.
Published: (2019-05-01)

Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates
by: Angela W. Xie, et al.
Published: (2021-08-01)

Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review
by: Manuel Sanchez-Diaz, et al.
Published: (2021-06-01)

Editorial: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products
by: Ivan Martin, et al.
Published: (2020-12-01)

Mesenchymal Stromal/Stem cells: Historical perspective and ongoing challenges
by: Maria Isabel Doria Rossi, et al.
Published: (2020-06-01)

Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures
by: Ruud Das, et al.
Published: (2019-07-01)

Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient Engraftment
by: Tiago L. Laundos, et al.
Published: (2021-02-01)

Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans
by: Anna Labedz-Maslowska, et al.
Published: (2021-07-01)

Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
by: E. Eduardo Sanchez-Castro, et al.
Published: (2021-02-01)

Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
by: Henry Caplan, et al.
Published: (2019-07-01)

Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
by: Joana R. Ferreira, et al.
Published: (2018-12-01)

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
by: Sharif Moradi, et al.
Published: (2019-11-01)

GARP is a key molecule for mesenchymal stromal cell responses to TGF‐β and fundamental to control mitochondrial ROS levels
by: Ana Belén Carrillo‐Gálvez, et al.
Published: (2020-05-01)

Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience
by: Valentina Becherucci, et al.
Published: (2018-05-01)

Cell Banking of HEK293T cell line for clinical-grade lentiviral particles manufacturing
by: Unai Perpiñá, et al.
Published: (2020-11-01)

Human Mesenchymal Stromal Cells Unveil an Unexpected Differentiation Potential toward the Dopaminergic Neuronal Lineage
by: Giulia Gaggi, et al.
Published: (2020-09-01)

MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism
by: Valerie Planat-Benard, et al.
Published: (2021-04-01)